Skip to content

Generate Biomedicines, Inc. GENB Operating lease liabilities

Operating lease liabilities at other companies

Virtu Financial logo
Virtu FinancialVIRT
-$13.67M-1.2%
Avis Budget Group logo
Avis Budget GroupCAR
-$308M-17.1%
Sherwin-Williams logo
Sherwin-WilliamsSHW
-$118.7M+4.4%
LKQ logo
LKQLKQ
-$1M
StoneX Group Inc. logo
StoneX Group Inc.SNEX
-$3.6M+2.7%
Cloudflare, Inc. logo
Cloudflare, Inc.NET
-$23M-81.4%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's operating lease liabilities?
Generate Biomedicines, Inc. (GENB) reported operating lease liabilities of -$1.84M in Q1 2026.